FIA
GMAB icon

FNY Investment Advisers’s Genmab GMAB Stock Holding History

FNY Investment Advisers’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,000
Closed -$646K – 907
2025
Q4 		$646K Buy
+21,000
New +$655K 0.18% 117
2025
Q3 		– Sell
-2
Closed – – 1335
2025
Q2 		$0 Buy
+2
New +$41 ﹤0.01% 1041
2023
Q2 		– Sell
-4,000
Closed -$151K – 596
2023
Q1 		$151K Buy
+4,000
New +$154K 0.17% 95
2022
Q1 		– Sell
-6,258
Closed -$247K – 804
2021
Q4 		$247K Buy
+6,258
New +$261K 0.13% 143
2021
Q2 		– Sell
-15,000
Closed -$492K – 858
2021
Q1 		$492K Buy
+15,000
New +$564K 0.18% 105
2020
Q4 		– Sell
-7,089
Closed -$259K – 840
2020
Q3 		$259K Buy
+7,089
New +$256K 0.11% 146

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

FNY Investment Advisers's GMAB Position: Q1 2026 in Review

FNY Investment Advisers sold out of Genmab (GMAB) in Q1 2026, closing a stake of 21,000 shares — an estimated $646K sold.

FNY Investment Advisers first reported a position in GMAB in Q3 2020 and held it in 6 quarters. The position peaked at $646K in Q4 2025. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • FNY Investment Advisers reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 21,000 Genmab shares in Q1 2026, an estimated $646K.
  • FNY Investment Advisers first reported a position in Genmab in Q3 2020 and held it in 6 quarters.
  • FNY Investment Advisers's Genmab position peaked at $646K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.